DLX5 Antibody - BSA Free

Immunohistochemistry-Paraffin: DLX5 Antibody [NBP1-85793]

Immunohistochemistry-Paraffin: DLX5 Antibody [NBP1-85793] - Staining of human skin shows moderate nuclear positivity in squamous epithelial cells.

Immunohistochemistry-Paraffin: DLX5 Antibody [NBP1-85793]

Immunohistochemistry-Paraffin: DLX5 Antibody [NBP1-85793] - Staining of human placenta shows weak nuclear positivity in trophoblastic cells.

Western Blot: DLX5 Antibody - BSA Free [NBP1-85793] -

Expression and enhancer association define two classes of EVT regulators.a Number of genes (blue), TFs (green), and SE-associated TFs (red) in class 2 and 3 genes. b Gene track view of H3K27ac signals near the candidate regulators of EVT differentiation, with red bars indicating SEs. c Expression patterns of early- and late-stage TF candidates during EVT differentiation. Values represent log2-transformed counts compared to the average. d Enriched motifs within the top 30% of H3K27ac peaks in EVT on differentiation day 3 were identified using the findMotifsGenome.pl module under HOMER (v4.11). p-values were calculated based on the default settings of the module, with a region size of 500 bp. e Western blot analysis demonstrating the expression patterns of EVT regulator candidates in CT27 TSC line. HLA-G expression was measured to validate EVT differentiation. ACTB was used as a loading control. *ZNF439 (lower band). Independent repeats, utilizing other TSC lines, were conducted as presented in Supplementary Fig. 2d. f Normalized transcripts per million value (nTPM) of EVT regulator candidates in scRNA-seq data of human first-trimester placenta (retrieved from the Human Protein Atlas19,102). Image collected and cropped by CiteAb from the following open publication (https://www.nature.com/articles/s41467-024-45669-2), licensed under a CC-BY license. Not internally tested by Novus Biologicals.

Chromatin Immunoprecipitation ChIP: DLX5 Antibody - BSA Free

ChIP-Exo-Seq composite graph for Anti-DLX5 tested in K562 cells. Strand-specific reads (blue: forward, red: reverse) and IgG controls (black: forward, grey: reverse) are plotted against the distance from a composite set of reference binding sites. The antibody exhibits robust target enrichment compared to a non-specific IgG control and precisely reveals its structural organization around the binding site. Data generated by Prof. B. F. Pugh's Lab at Cornell University.